ClinicMACs

DEVICE2 trials

Sponsors

M.D. Anderson Cancer Center, Dana-Farber Cancer Institute

Conditions

Hematologic MalignancyNeuroblastoma

Phase 2

Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma

TerminatedNCT00539500

M.D. Anderson Cancer CenterNeuroblastoma

Start: 2007-10-31End: 2012-09-05Updated: 2019-07-26

Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies

TerminatedNCT03717480

Dana-Farber Cancer InstituteHematologic Malignancy

Start: 2020-01-21End: 2021-04-26Updated: 2022-05-10